| Company Name: |
Ontores Biotech |
| Tel: |
0571-88760729 18072970094 |
| Email: |
supports@ontorespeptide.com |
|
| | Glycoprotein (276-286) Basic information |
| Product Name: | Glycoprotein (276-286) | | Synonyms: | Glycoprotein (276-286);L-Leucine, L-serylglycyl-L-valyl-L-α-glutamyl-L-asparaginyl-L-prolylglycylglycyl-L-tyrosyl-L-cysteinyl-;LCMV gp 276-286 (H-2 Db) | | CAS: | 160543-97-5 | | MF: | C46H70N12O17S | | MW: | 1095.19 | | EINECS: | | | Product Categories: | | | Mol File: | 160543-97-5.mol |  |
| | Glycoprotein (276-286) Chemical Properties |
| Boiling point | 1664.8±65.0 °C(Predicted) | | density | 1.378±0.06 g/cm3(Predicted) | | pka | 3.29±0.10(Predicted) | | Sequence | Ser-Gly-Val-Glu-Asn-Pro-Gly-Gly-Tyr-Cys-Leu |
| | Glycoprotein (276-286) Usage And Synthesis |
| Uses | Glycoprotein (276-286) is a Db-restricted peptide derived from lymphocytic choriomeningitis virus (LCMV) glycoprotein (GP), corresponds to amino acids 276-286[1]. | | References | [1] Oldstone MB, et al. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J Virol. 1995 Dec;69(12):7423-9. DOI:10.1128/JVI.69.12.7423-7429.1995 |
| | Glycoprotein (276-286) Preparation Products And Raw materials |
|